Support: 888-992-3836
Copyright © 2023 InvestorsHub Inc.
Replies to post #134603 on Biotech Values
DewDiligence
01/08/12 9:03 PM
#134604 RE: Biowatch #134603
rkrw
01/08/12 10:40 PM
#134613 RE: Biowatch #134603
01/12/12 6:45 PM
#134935 RE: Biowatch #134603
Two Inhibitex Inc. shareholders sued claiming Bristol-Myers Squibb Co.’s $2.5 billion buyout offer undervalues the drugmaker. Shareholders Charles C. Osborne Jr. and Hortensia Osborne are asking a judge to bar the proposed transaction. The deal will prevent Inhibitex shareholders from benefiting from the company’s long-term prospects, according to the complaint filed yesterday in Delaware Chancery Court.